Citation: F. Zannad et al., Treatment of congestive heart failure - Interfering the aldosterone-cardiac extracellular matrix relationship, HYPERTENSIO, 38(5), 2001, pp. 1227-1232
Authors:
Zannad, F
Alla, F
Dousset, B
Perez, A
Pitt, B
Citation: F. Zannad et al., Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES), CIRCULATION, 102(22), 2000, pp. 2700-2706
Authors:
Martinet, N
Alla, F
Farre, G
Labib, T
Drouot, H
Vidili, R
Picard, E
Gaube, MP
Le Faou, D
Siat, J
Borelly, J
Vermylen, P
Bazarbachi, T
Vignaud, JM
Martinet, Y
Citation: N. Martinet et al., Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions, CANCER RES, 60(11), 2000, pp. 2869-2875
Authors:
Angioi, M
Danchin, N
Alla, F
Gangloff, C
Sunthorn, H
Rodriguez, RM
Preiss, JP
Grentzinger, A
Houplon, P
Juilliere, Y
Cherrier, F
Citation: M. Angioi et al., Long-term outcome in patients treated by intracoronary stenting with ticlopidine and aspirin, and deleterious prognostic role of unstable angina pectoris, AM J CARD, 85(9), 2000, pp. 1065-1070
Authors:
Alla, F
Briancon, S
Juilliere, Y
Mertes, PM
Villemot, JP
Zannad, F
Citation: F. Alla et al., Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: The EPICAL study, AM HEART J, 139(5), 2000, pp. 895-904
Authors:
Zannad, F
Briancon, S
Julliere, Y
Mertes, PM
Villemot, JP
Alla, F
Virion, JM
Citation: F. Zannad et al., Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: The EPICAL study (vol 33, pg 734, 1999), J AM COL C, 34(4), 1999, pp. 1363-1363
Authors:
Zannad, F
Briancon, S
Juilliere, Y
Mertes, PM
Villemot, JP
Alla, F
Virion, JM
Citation: F. Zannad et al., Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: The EPICAL study, J AM COL C, 33(3), 1999, pp. 734-742